Spark Therapeutics Aktie
-
Deine Einschätzung
Was spricht für und gegen Spark Therapeutics in den nächsten Jahren?
Pro
Kontra
Rendite von Spark Therapeutics im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Spark Therapeutics | - | - | - | - | - | - | - |
| Iovance Biotherapeutics Inc. | 4,22 % | 13,90 % | 16,51 % | -55,45 % | 1,92 % | -64,80 % | -93,79 % |
| United Therapeutics | -0,27 % | 1,90 % | 3,47 % | 11,85 % | -4,38 % | 70,75 % | 181,79 % |
| Neurocrine Bioscience | 0,73 % | 6,61 % | -1,99 % | 0,82 % | -9,42 % | 14,20 % | 18,18 % |
Kommentare
News
Unity Software Is Falling—So Why Are Pros Getting More Bullish?
Unity Software (NYSE: U) experienced a jarring sell-off in mid-January 2026. The stock tumbled nearly 7% to close around $40.96, capping off its difficult start to 2026. For an investor looking
Why FuelCell Energy Stock Is Soaring After a Government Deal
After months of downward pressure, FuelCell Energy (NASDAQ: FCEL) has roared back to life.
Its stock price has risen more than 20% over three trading sessions ending in early December
Prediction: Nvidia Stock Could Reach $360 Sooner Than You Think
Nvidia (NASDAQ: NVDA) is transforming from a graphics processing unit (GPU) champion to an artificial intelligence (AI) infrastructure cash engine. Learn about Blackwell, DGX Spark, and DGX Cloud




